Sort
53,477 grants matching “addiction”
Vitamin D Modulation of Midbrain Dopamine Function: A 11C-PHNO PET Study in Healthy Humans
$836,846Marc N Potenza · Yale University · R01 · FY2019 · AT
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma
$836,753Tracy T Batchelor · Brigham And Women'S Hospital · U19 · FY2024 · CA
Cannabinoid Epigenomic and miRNA mechanisms impact HIV/SIV disease progression
$836,482Patricia E Molina · Lsu Health Sciences Center · R01 · FY2010 · DA
All-in-one Device for Forensic Toxicology Drug Screening
$836,432Justin Michael Wiseman · Wik Devices, Llc · R44 · FY2024 · DA
Examining craving-choice interaction using computational modeling and intracranial recording
$836,348Ignacio Saez · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DA
Development & Manufacture of Pharmaceutical Products for Addiction Treatment
$836,227Murty Pharmaceuticals, Inc. · N01 · FY2008 · DA
HIV/STI Prevention for Drug-Involved Couples
$836,117Nabila El-Bassel · Columbia Univ New York Morningside · R01 · FY2007 · DA
PET radiotracers to image the enzyme 11beta-hydroxysteroid dehydrogenase-1 (11beta-HSD1)
$836,039Yiyun Henry Huang · Yale University · R56 · FY2018 · MH
Neurobehavioral and Psychosocial Predictors of Health Risk Behaviors in Adolescence and Young Adulthood
$835,956Jungmeen Kim · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · DA
Evaluation of the therapeutic potential of exclusive antagonists of extrasynaptic NMDA receptors for the treatment of opioid use disorder
$835,697Elena Molokanova · Neurano Bioscience · R44 · FY2023 · DA
Research Core Psychotherapy Devleopment Research Center
$835,590Kathleen M Carroll · Yale University · P50 · FY2016 · DA
Clinical Trials Network: The Texas Node
$835,558Madhukar H Trivedi · Ut Southwestern Medical Center · U10 · FY2010 · DA
Project 2: Tobacco Marketing and Alternative Tobacco Use among College p182-230
$835,271Cheryl Lee Perry · University Of Texas Hlth Sci Ctr Houston · P50 · FY2014 · CA
DEVELOPMENT AND MANUFACTURE OF PHARMACEUTICAL PRODUCTS FOR ADDICTION TREATMENT
$835,249Ram B. Murty · · N01 · FY2007 · DA
Testing the Effects of Contingency Management and Behavioral Economics on Buprenorphine-Naloxone Treatment Adherence Using a Sequential Multiple Assignment Randomized Trial (SMART) Design
$834,831Karen J Derefinko · University Of Tennessee Health Sci Ctr · R61 · FY2019 · AT
Drugs On Learned & Spontaneous Behavior Of Experimental Animals
$834,824Steven Goldberg · National Institute On Drug Abuse · ZIA · FY2012 · DA
Medication Development for Protracted Abstinence in Alcoholism
$834,812Barbara J Mason · Scripps Research Institute, The · R01 · FY2009 · AA
Naltrexone for Opioid Dependent Released HIV+ Criminal Justice Populations
$834,318Sandra Ann Springer · Yale University · R01 · FY2012 · DA
Translational addiction neurobiology
$834,218Elliot A Stein · National Institute On Drug Abuse · ZIA · FY2019 · DA
Cognitive Control in Children of SUD Parents: A Longitudinal Multimodal MRI Study
$834,083Christina W. Hoven · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2018 · DA
Project-002
$834,008Cynthia I Campbell · Kaiser Foundation Research Institute · UG1 · FY2016 · DA
Integrating Addiction Research in Health Systems: The Addiction Research Network
$834,008Cynthia I Campbell · Kaiser Foundation Research Institute · UG1 · FY2016 · DA
Assessing central muscarinic acetylcholine type-1 receptors in cocaine use disorder with 11C-LSN3172176.
$833,971Gustavo Adolfo Angarita · Yale University · R33 · FY2025 · DA
Maternal Lifestyles Study Phase V
$833,957Seetha Shankaran · Wayne State University · U10 · FY2009 · DA
Cognitively-enhanced tDCS of the dorsolateral prefrontal cortex to reduce craving in cocaine addiction
$833,825Rita Z Goldstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DA